InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
64%
T+90 mean return
-2.0%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lippis Daniel J., CVP, JAPAC. Insider active across 1 company, notably Edwards Lifesciences Corp. Cumulatively, 27 reports have been recorded. Split: 0 buy · 1 sell. History available since 16 February 2024. The latest transaction was filed on 7 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations27 total
377 shares@ US$95.18Common StockSEC:0001225208-26-006535:0
619 sharesCommon StockSEC:0001225208-26-006263:0
619 sharesCommon StockSEC:0001225208-26-006263:1
1,019 shares@ US$59.25670.0001% mcap16.8% of flowCommon StockSEC:0001225208-26-004422:0
1,019 shares@ US$59.25670.0001% mcap16.8% of flowCommon StockSEC:0001225208-26-004422
1,019 shares@ US$59.256716.6% of flowCommon StockSEC:0001225208-26-000558
1,019 shares@ US$59.25670.0001% mcap16.6% of flowCommon StockSEC:0001225208-26-000558:0
1,019 shares@ US$59.256716.5% of flowCommon StockSEC:0001225208-25-009934
1,019 shares@ US$59.25670.0001% mcap16.5% of flowCommon StockSEC:0001225208-25-009934:0
271 shares@ US$73.682.3% of flowCommon StockSEC:0001225208-25-004997:0
4,225 shares0Common StockSEC:0001225208-25-004947:0
225 shares@ US$75.651.9% of flowCommon StockSEC:0001225208-25-004769:0
300 shares@ US$45.27671.6% of flowCommon StockSEC:0001225208-25-004176:0
400 shares@ US$45.27672.2% of flowCommon StockSEC:0001225208-25-003194:0
214 shares@ US$76.192.0% of flowCommon StockSEC:0001225208-25-001909:0
500 shares@ US$45.27672.8% of flowCommon StockSEC:0001225208-25-001710:0
500 shares@ US$45.27672.8% of flowCommon StockSEC:0001225208-25-000685:0
2,500 shares@ US$45.276713.9% of flowCommon StockSEC:0001225208-24-010858:0
500 shares@ US$45.27672.7% of flowCommon StockSEC:0001225208-24-007400:0
410 shares@ US$92.324.5% of flowCommon StockSEC:0001225208-24-007360:0
535 shares@ US$45.27672.9% of flowCommon StockSEC:0001225208-24-006926:0
377 shares@ US$86.723.9% of flowCommon StockSEC:0001225208-24-005983:0
4,660 shares0Common StockSEC:0001225208-24-005890:0
281 shares@ US$85.062.9% of flowCommon StockSEC:0001225208-24-005704:0
857 shares@ US$36.753.7% of flowCommon StockSEC:0001225208-24-005020:0
25 of 27 declarations
About Lippis Daniel J.
Daniel J. Lippis is associated with Edwards Lifesciences Corp as CVP, JAPAC, and CVP, TAVR. Although his functions are not specified, he plays an important role in the company's operations in these regions.
